<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oncotarget</journal-id><journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">ImpactJ</journal-id><journal-title-group><journal-title>Oncotarget</journal-title></journal-title-group><issn pub-type="epub">1949-2553</issn><publisher><publisher-name>Impact Journals LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30018752</article-id><article-id pub-id-type="pmc">6044371</article-id><article-id pub-id-type="publisher-id">25721</article-id><article-id pub-id-type="doi">10.18632/oncotarget.25721</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Garg</surname><given-names>Abhishek D.</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Elsen</surname><given-names>Sanne</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Krysko</surname><given-names>Dmitri V.</given-names></name><xref ref-type="aff" rid="A3"><sup>3</sup></xref><xref ref-type="aff" rid="A4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vandenabeele</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="A3"><sup>3</sup></xref><xref ref-type="aff" rid="A4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>de Witte</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Agostinis</surname><given-names>Patrizia</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><aff id="A1"><sup>1</sup> Cell Death Research &#x00026; Therapy (CDRT) Unit, Department of Cellular and Molecular Medicine, KU Leuven University of Leuven, Leuven, Belgium</aff><aff id="A2"><sup>2</sup> Laboratory for Molecular Biodiscovery, Department of Pharmaceutical Sciences, KU Leuven, Leuven, Belgium</aff><aff id="A3"><sup>3</sup> Molecular Signaling and Cell Death Unit, Department for Molecular Biomedical Research, VIB, Ghent, Belgium</aff><aff id="A4"><sup>4</sup> Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium</aff></contrib-group><pub-date pub-type="collection"><day>26</day><month>6</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>26</day><month>6</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>6</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>9</volume><issue>49</issue><fpage>29284</fpage><lpage>29284</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2018 Garg et al.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions></article-meta></front><body><p><bold>This article has been corrected:</bold> The correct <xref ref-type="fig" rid="sfig2">Supplementary Figure S2C</xref> is given below. The authors&#x02019; explanation is as follows:</p><fig id="sfig2" orientation="portrait" position="float"><label>Supplementary Figure S2</label><caption><title>Rat bladder carcinoma AY27 cells were treated or not (i.e. untreated controls/CNTR) with Hypericin-based Photodynamic Therapy (Hyp-PDT; 150 nM Hyp incubated for 16 h followed by irradiation with light fluence of 2.70 J/cm<sup>2</sup>) or mitoxantrone (MTX; 1 &#x003bc;M)</title><p>C. immunoblotting for other ER stress markers like upregulation of BiP/GRP78 or CHOP levels at indicated recovery time-points. The calculations based on band densitometry analysis are mentioned as applicable.</p></caption><graphic xlink:href="oncotarget-09-29284-g001"/></fig><p>Due to erroneous figure processing and oversight, unintended mistakes occurred during the assembly of <xref ref-type="fig" rid="sfig2">Supplementary Figure S2C</xref> &#x02013; specifically, the BiP/Grp78, CHOP and Actin panels for the AY27-PDT samples only. Using the source/raw data, we have now generated the correct <xref ref-type="fig" rid="sfig2">Supplementary Figure S2C</xref>.</p><p>The authors apologize for the oversight. The authors declare that this correction does not affect the description, interpretation, or the original conclusions of the manuscript.</p><p>Original article: Oncotarget. 2015; 6:26841-26860. <related-article id="d35e173" related-article-type="corrected-article" ext-link-type="doi" xlink:href="10.18632/oncotarget.4754" vol="6" page="26841">https://doi.org/10.18632/oncotarget.4754</related-article></p></body></article>